Given the evolution/expansion of the prostate cancer treatment landscape for metastatic castration-resistant prostate cancer (mCRPC), can you discuss key factors that shape your treatment approach?
How do patient characteristics such as age, performance status, and comorbidities influence that decision?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.